Cost-effectiveness of family history-based colorectal cancer screening in Australia

DA Ouakrim; A Boussioutas; T Lockett; JL Hopper; MA Jenkins

Journal article

Cost-effectiveness of family history-based colorectal cancer screening in Australia

DA Ouakrim, A Boussioutas, T Lockett, JL Hopper, MA Jenkins

BMC Cancer | BIOMED CENTRAL LTD | Published : 2014

DOI: 10.1186/1471-2407-14-261

Download PDF

Abstract

Background: With 14.234 diagnoses and over 4047 deaths reported in 2007, colorectal cancer (CRC) is the second most common cancer and second most common cause of cancer-related mortality in Australia. The direct treatment cost has recently been estimated to be around AU$1.2 billion for the year 2011, which corresponds to a four-fold increase, compared the cost reported in 2001. Excluding CRCs due to known rare genetic disorders, 20% to 25% of all CRCs occur in a familial aggregation setting due to genetic variants or shared environmental risk factors that are yet to be characterised. A targeted screening strategy addressed to this segment of the population is a potentially valuable tool ..

View full abstract

University of Melbourne Researchers

Driss Ait Ouakrim Author

Alex Boussioutas Author

Mark Jenkins Author

Related Projects (4)

CENTRE OF RESEARCH EXCELLENCE FOR REDUCING THE BURDEN OF COLORECTAL CANCER BY OPTIMISING SCREENING:EVIDENCE OF CLINICAL PRACTICE

Bowel cancer, the second most diagnosed and cause of cancer death is preventable. Low risk people need no screening or just inexpensive feca..

HOW EFFECTIVE IS BOWEL CANCER SCREENING AND WHO USES IT?

About 14,000 cases of bowel cancer occur annually in Australia despite the availability of life-saving screening. Most people do not receive..

COMPREHENISVE MODEL FOR COLORECTAL CANCER RISK

I am a genetic epidemiologist focused on bowel cancer risk. I will develop a comprehensive model to estimate individual cancer risk by study..

CENTRE OF RESEARCH EXCELLENCE FOR REDUCING THE BURDEN OF COLORECTAL CANCER BY OPTIMISING SCREENING:EVIDENCE OF CLINICAL PRACTICE

Bowel cancer, the second most diagnosed and cause of cancer death is preventable. Low risk people need no screening or just inexpensive feca..

Grants

Awarded by National Science Foundation

Funding Acknowledgements

Driss A Ouakrim was supported by a Commonwealth Scientific and Industrial Research Organisation PhD scholarship (CSIRO, Preventative Heath Flagship) and by an NHMRC Centre for Research Excellence grant (APP1042021). Mark A Jenkins is supported by a National Health & Medical Research Council, Australia Senior Research Fellow grant. The study was conducted independently of funding agencies.